Found 45 matching trials
Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic Leukemia PHASE1 Alemtuzumab is an anti CD52 monoclonal antibody. The CD52 antigen is presen...
Show More Location
Saint Antoine Hospital, Hematology Unit
Learn More & Join Trial
Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma PHASE1 This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Show More Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Learn More & Join Trial
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation PHASE1 Background:
Blood cancers (such as leukemias or lymphomas) often do not re...
Show More Learn More & Join Trial
Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation PHASE1 The goal of this clinical research study is to find out if giving a boost o...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-altered Glioma EARLY_PHASE1 The investigators will evaluate the sensitivity of ctDNA from plasma and CS...
Show More Learn More & Join Trial
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis PHASE1 Background:
GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas PHASE2 The goal of this clinical research study is to learn if it is possible to c...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease PHASE1 This is a Phase 1/Phase 2 study assessing liothyronine (L-T3) immunotherapy...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients PHASE2 This will be a multi-center, prospective, randomized, single-blinded, place...
Show More Location
Sarcoma Oncology Research Center, LLC
Learn More & Join Trial
Control Cohort CTRL COH NA Autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS...
Show More Location
Hospices Civils de Lyon
Learn More & Join Trial